Skip to content
Business Segments · Cost of revenues

Life Sciences Solutions — Cost of revenues

Thermo Fisher Scientific Life Sciences Solutions — Cost of revenues decreased by 15.4% to $1B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 17.4%, from $855M to $1B. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementSegment
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2023
Last reportedQ1 2026May 1, 2026

How to read this metric

A decrease relative to revenue indicates improved manufacturing efficiency or better pricing power, while an increase suggests rising input costs.

Detailed definition

The direct costs attributable to the production and delivery of goods sold by the Life Sciences Solutions segment, inclu...

Peer comparison

Standard metric for all manufacturing and product-based business segments.

Metric ID: tmo_segment_life_sciences_solutions_cost_of_revenues

Historical Data

11 periods
 Q1 '23Q2 '23Q3 '23Q4 '23Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$1.02B$1.02B$1.02B$1.02B$907M$973M$855M$926M$961M$1.19B$1B
QoQ Change+0.0%+0.0%+0.0%-11.0%+7.3%-12.1%+8.3%+3.8%+23.5%-15.4%
YoY Change-11.0%-4.6%+6.0%+22.0%+17.4%
Range$855M$1.19B
CAGR-0.6%
Avg YoY Growth+6.0%
Median YoY Growth+6.0%

Frequently Asked Questions

What is Thermo Fisher Scientific's life sciences solutions — cost of revenues?
Thermo Fisher Scientific (TMO) reported life sciences solutions — cost of revenues of $1B in Q1 2026.
How has Thermo Fisher Scientific's life sciences solutions — cost of revenues changed year-over-year?
Thermo Fisher Scientific's life sciences solutions — cost of revenues increased by 17.4% year-over-year, from $855M to $1B.
What does life sciences solutions — cost of revenues mean?
The direct costs required to manufacture and deliver the products sold by the segment.